In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization

Detalhes bibliográficos
Autor(a) principal: Olivier, Celso Eduardo
Data de Publicação: 2012
Outros Autores: Lima, Regiane Patussi dos Santos, Pinto, Daiana Guedes, Santos, Raquel Acacia Pereira Goncalves dos, Silva, Grayce Katlen Moreno da, Lorena, Sônia Letícia Silva, Villas-Boas, Mariana Battaglin, Netto, Flávia Maria, Zollner, Ricardo de Lima
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/47930
Resumo: OBJECTIVE: To explore the use of β-lactoglobulin polymerized using microbial transglutaminase and heating to identify whether protein polymerization could reduce in vivo allergenicity and maintain in vitro and ex vivo immunoreactivity for use in tolerance-induction protocols. METHODS: Based on previous protocols applied in mice and children, we performed in vivo challenges (using a skin prick test) with native and polymerized β-lactoglobulin in adult patients with an IgE-mediated allergy to plactoglobulin. In vitro humoral immunoreactivity was analyzed using immunoblotting. Cell-mediated immunoreactivity was analyzed using ex vivo challenges with native and polymerized β-lactoglobulin and monitored by leukocyte adherence inhibition tests. RESULTS: The skin tests demonstrated that there was a significant reduction in immediate cutaneous reactivity after polymerization. Polymerization did not decrease the immunoblotting detection of s-IgE specific to β-lactoglobulin. Cell-mediated immunoreactivity, as assessed by ex vivo challenges and leukocyte adherence inhibition tests, did not exhibit significant differences between leukocytes challenged with native versus polymerized β-lactoglobulin. CONCLUSIONS: The polymerization of β-lactoglobulin decreased in vivo allergenicity and did not decrease in vitro humoral or ex vivo cell-mediated immunoreactivity. Therefore, we conclude that inducing polymerization using transglutaminase represents a promising technique to produce suitable molecules for the purpose of designing oral/ sublingual tolerance induction protocols for the treatment of allergies.
id USP-19_6621fb6614eedac016d1a37d59be567b
oai_identifier_str oai:revistas.usp.br:article/47930
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerizationBeta-lactoglobulinMilk HypersensitivityLeukocyte Adherence Inhibition TestPolymerizationImmune TolerancezOBJECTIVE: To explore the use of β-lactoglobulin polymerized using microbial transglutaminase and heating to identify whether protein polymerization could reduce in vivo allergenicity and maintain in vitro and ex vivo immunoreactivity for use in tolerance-induction protocols. METHODS: Based on previous protocols applied in mice and children, we performed in vivo challenges (using a skin prick test) with native and polymerized β-lactoglobulin in adult patients with an IgE-mediated allergy to plactoglobulin. In vitro humoral immunoreactivity was analyzed using immunoblotting. Cell-mediated immunoreactivity was analyzed using ex vivo challenges with native and polymerized β-lactoglobulin and monitored by leukocyte adherence inhibition tests. RESULTS: The skin tests demonstrated that there was a significant reduction in immediate cutaneous reactivity after polymerization. Polymerization did not decrease the immunoblotting detection of s-IgE specific to β-lactoglobulin. Cell-mediated immunoreactivity, as assessed by ex vivo challenges and leukocyte adherence inhibition tests, did not exhibit significant differences between leukocytes challenged with native versus polymerized β-lactoglobulin. CONCLUSIONS: The polymerization of β-lactoglobulin decreased in vivo allergenicity and did not decrease in vitro humoral or ex vivo cell-mediated immunoreactivity. Therefore, we conclude that inducing polymerization using transglutaminase represents a promising technique to produce suitable molecules for the purpose of designing oral/ sublingual tolerance induction protocols for the treatment of allergies.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2012-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/4793010.6061/clinics/2012(10)09Clinics; Vol. 67 No. 10 (2012); 1171-1179Clinics; v. 67 n. 10 (2012); 1171-1179Clinics; Vol. 67 Núm. 10 (2012); 1171-11791980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/47930/51670Olivier, Celso EduardoLima, Regiane Patussi dos SantosPinto, Daiana GuedesSantos, Raquel Acacia Pereira Goncalves dosSilva, Grayce Katlen Moreno daLorena, Sônia Letícia SilvaVillas-Boas, Mariana BattaglinNetto, Flávia MariaZollner, Ricardo de Limainfo:eu-repo/semantics/openAccess2012-12-13T11:00:46Zoai:revistas.usp.br:article/47930Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-12-13T11:00:46Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
title In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
spellingShingle In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
Olivier, Celso Eduardo
Beta-lactoglobulin
Milk Hypersensitivity
Leukocyte Adherence Inhibition Test
Polymerization
Immune Tolerancez
title_short In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
title_full In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
title_fullStr In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
title_full_unstemmed In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
title_sort In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization
author Olivier, Celso Eduardo
author_facet Olivier, Celso Eduardo
Lima, Regiane Patussi dos Santos
Pinto, Daiana Guedes
Santos, Raquel Acacia Pereira Goncalves dos
Silva, Grayce Katlen Moreno da
Lorena, Sônia Letícia Silva
Villas-Boas, Mariana Battaglin
Netto, Flávia Maria
Zollner, Ricardo de Lima
author_role author
author2 Lima, Regiane Patussi dos Santos
Pinto, Daiana Guedes
Santos, Raquel Acacia Pereira Goncalves dos
Silva, Grayce Katlen Moreno da
Lorena, Sônia Letícia Silva
Villas-Boas, Mariana Battaglin
Netto, Flávia Maria
Zollner, Ricardo de Lima
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Olivier, Celso Eduardo
Lima, Regiane Patussi dos Santos
Pinto, Daiana Guedes
Santos, Raquel Acacia Pereira Goncalves dos
Silva, Grayce Katlen Moreno da
Lorena, Sônia Letícia Silva
Villas-Boas, Mariana Battaglin
Netto, Flávia Maria
Zollner, Ricardo de Lima
dc.subject.por.fl_str_mv Beta-lactoglobulin
Milk Hypersensitivity
Leukocyte Adherence Inhibition Test
Polymerization
Immune Tolerancez
topic Beta-lactoglobulin
Milk Hypersensitivity
Leukocyte Adherence Inhibition Test
Polymerization
Immune Tolerancez
description OBJECTIVE: To explore the use of β-lactoglobulin polymerized using microbial transglutaminase and heating to identify whether protein polymerization could reduce in vivo allergenicity and maintain in vitro and ex vivo immunoreactivity for use in tolerance-induction protocols. METHODS: Based on previous protocols applied in mice and children, we performed in vivo challenges (using a skin prick test) with native and polymerized β-lactoglobulin in adult patients with an IgE-mediated allergy to plactoglobulin. In vitro humoral immunoreactivity was analyzed using immunoblotting. Cell-mediated immunoreactivity was analyzed using ex vivo challenges with native and polymerized β-lactoglobulin and monitored by leukocyte adherence inhibition tests. RESULTS: The skin tests demonstrated that there was a significant reduction in immediate cutaneous reactivity after polymerization. Polymerization did not decrease the immunoblotting detection of s-IgE specific to β-lactoglobulin. Cell-mediated immunoreactivity, as assessed by ex vivo challenges and leukocyte adherence inhibition tests, did not exhibit significant differences between leukocytes challenged with native versus polymerized β-lactoglobulin. CONCLUSIONS: The polymerization of β-lactoglobulin decreased in vivo allergenicity and did not decrease in vitro humoral or ex vivo cell-mediated immunoreactivity. Therefore, we conclude that inducing polymerization using transglutaminase represents a promising technique to produce suitable molecules for the purpose of designing oral/ sublingual tolerance induction protocols for the treatment of allergies.
publishDate 2012
dc.date.none.fl_str_mv 2012-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/47930
10.6061/clinics/2012(10)09
url https://www.revistas.usp.br/clinics/article/view/47930
identifier_str_mv 10.6061/clinics/2012(10)09
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/47930/51670
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 67 No. 10 (2012); 1171-1179
Clinics; v. 67 n. 10 (2012); 1171-1179
Clinics; Vol. 67 Núm. 10 (2012); 1171-1179
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222759167459328